Table of Content

1 Study Coverage
1.1 ICOS Antibody Product Introduction
1.2 Market by Type
1.2.1 Global ICOS Antibody Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Monoclonal Antibody
1.2.3 Polyclonal Antibody
1.3 Market by Application
1.3.1 Global ICOS Antibody Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Flow Cytometry
1.3.3 ELISA
1.3.4 Western Blot
1.3.5 Immunoprecipitation
1.3.6 Immunofluorescence
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global ICOS Antibody Sales Estimates and Forecasts 2018-2029
2.2 Global ICOS Antibody Revenue by Region
2.2.1 Global ICOS Antibody Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global ICOS Antibody Revenue by Region (2018-2024)
2.2.3 Global ICOS Antibody Revenue by Region (2024-2029)
2.2.4 Global ICOS Antibody Revenue Market Share by Region (2018-2029)
2.3 Global ICOS Antibody Sales Estimates and Forecasts 2018-2029
2.4 Global ICOS Antibody Sales by Region
2.4.1 Global ICOS Antibody Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global ICOS Antibody Sales by Region (2018-2024)
2.4.3 Global ICOS Antibody Sales by Region (2024-2029)
2.4.4 Global ICOS Antibody Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global ICOS Antibody Sales by Manufacturers
3.1.1 Global ICOS Antibody Sales by Manufacturers (2018-2024)
3.1.2 Global ICOS Antibody Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of ICOS Antibody in 2022
3.2 Global ICOS Antibody Revenue by Manufacturers
3.2.1 Global ICOS Antibody Revenue by Manufacturers (2018-2024)
3.2.2 Global ICOS Antibody Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by ICOS Antibody Revenue in 2022
3.3 Global Key Players of ICOS Antibody, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global ICOS Antibody Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global ICOS Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of ICOS Antibody, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of ICOS Antibody, Product Offered and Application
3.8 Global Key Manufacturers of ICOS Antibody, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global ICOS Antibody Sales by Type
4.1.1 Global ICOS Antibody Historical Sales by Type (2018-2024)
4.1.2 Global ICOS Antibody Forecasted Sales by Type (2024-2029)
4.1.3 Global ICOS Antibody Sales Market Share by Type (2018-2029)
4.2 Global ICOS Antibody Revenue by Type
4.2.1 Global ICOS Antibody Historical Revenue by Type (2018-2024)
4.2.2 Global ICOS Antibody Forecasted Revenue by Type (2024-2029)
4.2.3 Global ICOS Antibody Revenue Market Share by Type (2018-2029)
4.3 Global ICOS Antibody Price by Type
4.3.1 Global ICOS Antibody Price by Type (2018-2024)
4.3.2 Global ICOS Antibody Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global ICOS Antibody Sales by Application
5.1.1 Global ICOS Antibody Historical Sales by Application (2018-2024)
5.1.2 Global ICOS Antibody Forecasted Sales by Application (2024-2029)
5.1.3 Global ICOS Antibody Sales Market Share by Application (2018-2029)
5.2 Global ICOS Antibody Revenue by Application
5.2.1 Global ICOS Antibody Historical Revenue by Application (2018-2024)
5.2.2 Global ICOS Antibody Forecasted Revenue by Application (2024-2029)
5.2.3 Global ICOS Antibody Revenue Market Share by Application (2018-2029)
5.3 Global ICOS Antibody Price by Application
5.3.1 Global ICOS Antibody Price by Application (2018-2024)
5.3.2 Global ICOS Antibody Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada ICOS Antibody Market Size by Type
6.1.1 US & Canada ICOS Antibody Sales by Type (2018-2029)
6.1.2 US & Canada ICOS Antibody Revenue by Type (2018-2029)
6.2 US & Canada ICOS Antibody Market Size by Application
6.2.1 US & Canada ICOS Antibody Sales by Application (2018-2029)
6.2.2 US & Canada ICOS Antibody Revenue by Application (2018-2029)
6.3 US & Canada ICOS Antibody Market Size by Country
6.3.1 US & Canada ICOS Antibody Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada ICOS Antibody Sales by Country (2018-2029)
6.3.3 US & Canada ICOS Antibody Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe ICOS Antibody Market Size by Type
7.1.1 Europe ICOS Antibody Sales by Type (2018-2029)
7.1.2 Europe ICOS Antibody Revenue by Type (2018-2029)
7.2 Europe ICOS Antibody Market Size by Application
7.2.1 Europe ICOS Antibody Sales by Application (2018-2029)
7.2.2 Europe ICOS Antibody Revenue by Application (2018-2029)
7.3 Europe ICOS Antibody Market Size by Country
7.3.1 Europe ICOS Antibody Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe ICOS Antibody Sales by Country (2018-2029)
7.3.3 Europe ICOS Antibody Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China ICOS Antibody Market Size
8.1.1 China ICOS Antibody Sales (2018-2029)
8.1.2 China ICOS Antibody Revenue (2018-2029)
8.2 China ICOS Antibody Market Size by Application
8.2.1 China ICOS Antibody Sales by Application (2018-2029)
8.2.2 China ICOS Antibody Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia ICOS Antibody Market Size by Type
9.1.1 Asia ICOS Antibody Sales by Type (2018-2029)
9.1.2 Asia ICOS Antibody Revenue by Type (2018-2029)
9.2 Asia ICOS Antibody Market Size by Application
9.2.1 Asia ICOS Antibody Sales by Application (2018-2029)
9.2.2 Asia ICOS Antibody Revenue by Application (2018-2029)
9.3 Asia ICOS Antibody Sales by Region
9.3.1 Asia ICOS Antibody Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia ICOS Antibody Revenue by Region (2018-2029)
9.3.3 Asia ICOS Antibody Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America ICOS Antibody Market Size by Type
10.1.1 Middle East, Africa and Latin America ICOS Antibody Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America ICOS Antibody Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America ICOS Antibody Market Size by Application
10.2.1 Middle East, Africa and Latin America ICOS Antibody Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America ICOS Antibody Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America ICOS Antibody Sales by Country
10.3.1 Middle East, Africa and Latin America ICOS Antibody Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America ICOS Antibody Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America ICOS Antibody Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Sino Biological, Inc.
11.1.1 Sino Biological, Inc. Company Information
11.1.2 Sino Biological, Inc. Overview
11.1.3 Sino Biological, Inc. ICOS Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Sino Biological, Inc. ICOS Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sino Biological, Inc. Recent Developments
11.2 Cell Signaling Technology, Inc.
11.2.1 Cell Signaling Technology, Inc. Company Information
11.2.2 Cell Signaling Technology, Inc. Overview
11.2.3 Cell Signaling Technology, Inc. ICOS Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Cell Signaling Technology, Inc. ICOS Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Cell Signaling Technology, Inc. Recent Developments
11.3 Bio-Techne
11.3.1 Bio-Techne Company Information
11.3.2 Bio-Techne Overview
11.3.3 Bio-Techne ICOS Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Bio-Techne ICOS Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bio-Techne Recent Developments
11.4 OriGene Technologies, Inc.
11.4.1 OriGene Technologies, Inc. Company Information
11.4.2 OriGene Technologies, Inc. Overview
11.4.3 OriGene Technologies, Inc. ICOS Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 OriGene Technologies, Inc. ICOS Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 OriGene Technologies, Inc. Recent Developments
11.5 LifeSpan BioSciences, Inc
11.5.1 LifeSpan BioSciences, Inc Company Information
11.5.2 LifeSpan BioSciences, Inc Overview
11.5.3 LifeSpan BioSciences, Inc ICOS Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 LifeSpan BioSciences, Inc ICOS Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 LifeSpan BioSciences, Inc Recent Developments
11.6 Abbexa
11.6.1 Abbexa Company Information
11.6.2 Abbexa Overview
11.6.3 Abbexa ICOS Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Abbexa ICOS Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Abbexa Recent Developments
11.7 MyBiosource, Inc.
11.7.1 MyBiosource, Inc. Company Information
11.7.2 MyBiosource, Inc. Overview
11.7.3 MyBiosource, Inc. ICOS Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 MyBiosource, Inc. ICOS Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 MyBiosource, Inc. Recent Developments
11.8 Biorbyt
11.8.1 Biorbyt Company Information
11.8.2 Biorbyt Overview
11.8.3 Biorbyt ICOS Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Biorbyt ICOS Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Biorbyt Recent Developments
11.9 Creative Biolabs
11.9.1 Creative Biolabs Company Information
11.9.2 Creative Biolabs Overview
11.9.3 Creative Biolabs ICOS Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Creative Biolabs ICOS Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Creative Biolabs Recent Developments
11.10 GeneTex
11.10.1 GeneTex Company Information
11.10.2 GeneTex Overview
11.10.3 GeneTex ICOS Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 GeneTex ICOS Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 GeneTex Recent Developments
11.11 Arigo Biolaboratories Corp.
11.11.1 Arigo Biolaboratories Corp. Company Information
11.11.2 Arigo Biolaboratories Corp. Overview
11.11.3 Arigo Biolaboratories Corp. ICOS Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Arigo Biolaboratories Corp. ICOS Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Arigo Biolaboratories Corp. Recent Developments
11.12 Abcam
11.12.1 Abcam Company Information
11.12.2 Abcam Overview
11.12.3 Abcam ICOS Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Abcam ICOS Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Abcam Recent Developments
11.13 RayBiotech, Inc.
11.13.1 RayBiotech, Inc. Company Information
11.13.2 RayBiotech, Inc. Overview
11.13.3 RayBiotech, Inc. ICOS Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 RayBiotech, Inc. ICOS Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 RayBiotech, Inc. Recent Developments
11.14 Assay Genie
11.14.1 Assay Genie Company Information
11.14.2 Assay Genie Overview
11.14.3 Assay Genie ICOS Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Assay Genie ICOS Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Assay Genie Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 ICOS Antibody Industry Chain Analysis
12.2 ICOS Antibody Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 ICOS Antibody Production Mode & Process
12.4 ICOS Antibody Sales and Marketing
12.4.1 ICOS Antibody Sales Channels
12.4.2 ICOS Antibody Distributors
12.5 ICOS Antibody Customers
13 Market Dynamics
13.1 ICOS Antibody Industry Trends
13.2 ICOS Antibody Market Drivers
13.3 ICOS Antibody Market Challenges
13.4 ICOS Antibody Market Restraints
14 Key Findings in The Global ICOS Antibody Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global ICOS Antibody Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Monoclonal Antibody
Table 3. Major Manufacturers of Polyclonal Antibody
Table 4. Global ICOS Antibody Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global ICOS Antibody Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global ICOS Antibody Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global ICOS Antibody Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global ICOS Antibody Revenue Market Share by Region (2018-2024)
Table 9. Global ICOS Antibody Revenue Market Share by Region (2024-2029)
Table 10. Global ICOS Antibody Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global ICOS Antibody Sales by Region (2018-2024) & (K Units)
Table 12. Global ICOS Antibody Sales by Region (2024-2029) & (K Units)
Table 13. Global ICOS Antibody Sales Market Share by Region (2018-2024)
Table 14. Global ICOS Antibody Sales Market Share by Region (2024-2029)
Table 15. Global ICOS Antibody Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global ICOS Antibody Sales Share by Manufacturers (2018-2024)
Table 17. Global ICOS Antibody Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global ICOS Antibody Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of ICOS Antibody, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. ICOS Antibody Price by Manufacturers 2018-2024 (US$/Unit)
Table 21. Global ICOS Antibody Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global ICOS Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ICOS Antibody as of 2022)
Table 23. Global Key Manufacturers of ICOS Antibody, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of ICOS Antibody, Product Offered and Application
Table 25. Global Key Manufacturers of ICOS Antibody, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global ICOS Antibody Sales by Type (2018-2024) & (K Units)
Table 28. Global ICOS Antibody Sales by Type (2024-2029) & (K Units)
Table 29. Global ICOS Antibody Sales Share by Type (2018-2024)
Table 30. Global ICOS Antibody Sales Share by Type (2024-2029)
Table 31. Global ICOS Antibody Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global ICOS Antibody Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global ICOS Antibody Revenue Share by Type (2018-2024)
Table 34. Global ICOS Antibody Revenue Share by Type (2024-2029)
Table 35. ICOS Antibody Price by Type (2018-2024) & (US$/Unit)
Table 36. Global ICOS Antibody Price Forecast by Type (2024-2029) & (US$/Unit)
Table 37. Global ICOS Antibody Sales by Application (2018-2024) & (K Units)
Table 38. Global ICOS Antibody Sales by Application (2024-2029) & (K Units)
Table 39. Global ICOS Antibody Sales Share by Application (2018-2024)
Table 40. Global ICOS Antibody Sales Share by Application (2024-2029)
Table 41. Global ICOS Antibody Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global ICOS Antibody Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global ICOS Antibody Revenue Share by Application (2018-2024)
Table 44. Global ICOS Antibody Revenue Share by Application (2024-2029)
Table 45. ICOS Antibody Price by Application (2018-2024) & (US$/Unit)
Table 46. Global ICOS Antibody Price Forecast by Application (2024-2029) & (US$/Unit)
Table 47. US & Canada ICOS Antibody Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada ICOS Antibody Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada ICOS Antibody Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada ICOS Antibody Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada ICOS Antibody Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada ICOS Antibody Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada ICOS Antibody Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada ICOS Antibody Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada ICOS Antibody Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada ICOS Antibody Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada ICOS Antibody Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada ICOS Antibody Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada ICOS Antibody Sales by Country (2024-2029) & (K Units)
Table 60. Europe ICOS Antibody Sales by Type (2018-2024) & (K Units)
Table 61. Europe ICOS Antibody Sales by Type (2024-2029) & (K Units)
Table 62. Europe ICOS Antibody Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe ICOS Antibody Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe ICOS Antibody Sales by Application (2018-2024) & (K Units)
Table 65. Europe ICOS Antibody Sales by Application (2024-2029) & (K Units)
Table 66. Europe ICOS Antibody Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe ICOS Antibody Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe ICOS Antibody Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe ICOS Antibody Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe ICOS Antibody Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe ICOS Antibody Sales by Country (2018-2024) & (K Units)
Table 72. Europe ICOS Antibody Sales by Country (2024-2029) & (K Units)
Table 73. China ICOS Antibody Sales by Type (2018-2024) & (K Units)
Table 74. China ICOS Antibody Sales by Type (2024-2029) & (K Units)
Table 75. China ICOS Antibody Revenue by Type (2018-2024) & (US$ Million)
Table 76. China ICOS Antibody Revenue by Type (2024-2029) & (US$ Million)
Table 77. China ICOS Antibody Sales by Application (2018-2024) & (K Units)
Table 78. China ICOS Antibody Sales by Application (2024-2029) & (K Units)
Table 79. China ICOS Antibody Revenue by Application (2018-2024) & (US$ Million)
Table 80. China ICOS Antibody Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia ICOS Antibody Sales by Type (2018-2024) & (K Units)
Table 82. Asia ICOS Antibody Sales by Type (2024-2029) & (K Units)
Table 83. Asia ICOS Antibody Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia ICOS Antibody Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia ICOS Antibody Sales by Application (2018-2024) & (K Units)
Table 86. Asia ICOS Antibody Sales by Application (2024-2029) & (K Units)
Table 87. Asia ICOS Antibody Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia ICOS Antibody Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia ICOS Antibody Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia ICOS Antibody Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia ICOS Antibody Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia ICOS Antibody Sales by Region (2018-2024) & (K Units)
Table 93. Asia ICOS Antibody Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America ICOS Antibody Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America ICOS Antibody Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America ICOS Antibody Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America ICOS Antibody Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America ICOS Antibody Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America ICOS Antibody Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America ICOS Antibody Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America ICOS Antibody Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America ICOS Antibody Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America ICOS Antibody Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America ICOS Antibody Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America ICOS Antibody Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America ICOS Antibody Sales by Country (2024-2029) & (K Units)
Table 107. Sino Biological, Inc. Company Information
Table 108. Sino Biological, Inc. Description and Major Businesses
Table 109. Sino Biological, Inc. ICOS Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Sino Biological, Inc. ICOS Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Sino Biological, Inc. Recent Developments
Table 112. Cell Signaling Technology, Inc. Company Information
Table 113. Cell Signaling Technology, Inc. Description and Major Businesses
Table 114. Cell Signaling Technology, Inc. ICOS Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Cell Signaling Technology, Inc. ICOS Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Cell Signaling Technology, Inc. Recent Developments
Table 117. Bio-Techne Company Information
Table 118. Bio-Techne Description and Major Businesses
Table 119. Bio-Techne ICOS Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Bio-Techne ICOS Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Bio-Techne Recent Developments
Table 122. OriGene Technologies, Inc. Company Information
Table 123. OriGene Technologies, Inc. Description and Major Businesses
Table 124. OriGene Technologies, Inc. ICOS Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. OriGene Technologies, Inc. ICOS Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. OriGene Technologies, Inc. Recent Developments
Table 127. LifeSpan BioSciences, Inc Company Information
Table 128. LifeSpan BioSciences, Inc Description and Major Businesses
Table 129. LifeSpan BioSciences, Inc ICOS Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. LifeSpan BioSciences, Inc ICOS Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. LifeSpan BioSciences, Inc Recent Developments
Table 132. Abbexa Company Information
Table 133. Abbexa Description and Major Businesses
Table 134. Abbexa ICOS Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. Abbexa ICOS Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Abbexa Recent Developments
Table 137. MyBiosource, Inc. Company Information
Table 138. MyBiosource, Inc. Description and Major Businesses
Table 139. MyBiosource, Inc. ICOS Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. MyBiosource, Inc. ICOS Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. MyBiosource, Inc. Recent Developments
Table 142. Biorbyt Company Information
Table 143. Biorbyt Description and Major Businesses
Table 144. Biorbyt ICOS Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. Biorbyt ICOS Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Biorbyt Recent Developments
Table 147. Creative Biolabs Company Information
Table 148. Creative Biolabs Description and Major Businesses
Table 149. Creative Biolabs ICOS Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. Creative Biolabs ICOS Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Creative Biolabs Recent Developments
Table 152. GeneTex Company Information
Table 153. GeneTex Description and Major Businesses
Table 154. GeneTex ICOS Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. GeneTex ICOS Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. GeneTex Recent Developments
Table 157. Arigo Biolaboratories Corp. Company Information
Table 158. Arigo Biolaboratories Corp. Description and Major Businesses
Table 159. Arigo Biolaboratories Corp. ICOS Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. Arigo Biolaboratories Corp. ICOS Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Arigo Biolaboratories Corp. Recent Developments
Table 162. Abcam Company Information
Table 163. Abcam Description and Major Businesses
Table 164. Abcam ICOS Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 165. Abcam ICOS Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Abcam Recent Developments
Table 167. RayBiotech, Inc. Company Information
Table 168. RayBiotech, Inc. Description and Major Businesses
Table 169. RayBiotech, Inc. ICOS Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 170. RayBiotech, Inc. ICOS Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. RayBiotech, Inc. Recent Developments
Table 172. Assay Genie Company Information
Table 173. Assay Genie Description and Major Businesses
Table 174. Assay Genie ICOS Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 175. Assay Genie ICOS Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Assay Genie Recent Developments
Table 177. Key Raw Materials Lists
Table 178. Raw Materials Key Suppliers Lists
Table 179. ICOS Antibody Distributors List
Table 180. ICOS Antibody Customers List
Table 181. ICOS Antibody Market Trends
Table 182. ICOS Antibody Market Drivers
Table 183. ICOS Antibody Market Challenges
Table 184. ICOS Antibody Market Restraints
Table 185. Research Programs/Design for This Report
Table 186. Key Data Information from Secondary Sources
Table 187. Key Data Information from Primary Sources
List of Figures
Figure 1. ICOS Antibody Product Picture
Figure 2. Global ICOS Antibody Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global ICOS Antibody Market Share by Type in 2022 & 2029
Figure 4. Monoclonal Antibody Product Picture
Figure 5. Polyclonal Antibody Product Picture
Figure 6. Global ICOS Antibody Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global ICOS Antibody Market Share by Application in 2022 & 2029
Figure 8. Flow Cytometry
Figure 9. ELISA
Figure 10. Western Blot
Figure 11. Immunoprecipitation
Figure 12. Immunofluorescence
Figure 13. Others
Figure 14. ICOS Antibody Report Years Considered
Figure 15. Global ICOS Antibody Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global ICOS Antibody Revenue 2018-2029 (US$ Million)
Figure 17. Global ICOS Antibody Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 18. Global ICOS Antibody Revenue Market Share by Region (2018-2029)
Figure 19. Global ICOS Antibody Sales 2018-2029 ((K Units)
Figure 20. Global ICOS Antibody Sales Market Share by Region (2018-2029)
Figure 21. US & Canada ICOS Antibody Sales YoY (2018-2029) & (K Units)
Figure 22. US & Canada ICOS Antibody Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Europe ICOS Antibody Sales YoY (2018-2029) & (K Units)
Figure 24. Europe ICOS Antibody Revenue YoY (2018-2029) & (US$ Million)
Figure 25. China ICOS Antibody Sales YoY (2018-2029) & (K Units)
Figure 26. China ICOS Antibody Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Asia (excluding China) ICOS Antibody Sales YoY (2018-2029) & (K Units)
Figure 28. Asia (excluding China) ICOS Antibody Revenue YoY (2018-2029) & (US$ Million)
Figure 29. Middle East, Africa and Latin America ICOS Antibody Sales YoY (2018-2029) & (K Units)
Figure 30. Middle East, Africa and Latin America ICOS Antibody Revenue YoY (2018-2029) & (US$ Million)
Figure 31. The ICOS Antibody Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 32. The Top 5 and 10 Largest Manufacturers of ICOS Antibody in the World: Market Share by ICOS Antibody Revenue in 2022
Figure 33. Global ICOS Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 34. Global ICOS Antibody Sales Market Share by Type (2018-2029)
Figure 35. Global ICOS Antibody Revenue Market Share by Type (2018-2029)
Figure 36. Global ICOS Antibody Sales Market Share by Application (2018-2029)
Figure 37. Global ICOS Antibody Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada ICOS Antibody Sales Market Share by Type (2018-2029)
Figure 39. US & Canada ICOS Antibody Revenue Market Share by Type (2018-2029)
Figure 40. US & Canada ICOS Antibody Sales Market Share by Application (2018-2029)
Figure 41. US & Canada ICOS Antibody Revenue Market Share by Application (2018-2029)
Figure 42. US & Canada ICOS Antibody Revenue Share by Country (2018-2029)
Figure 43. US & Canada ICOS Antibody Sales Share by Country (2018-2029)
Figure 44. U.S. ICOS Antibody Revenue (2018-2029) & (US$ Million)
Figure 45. Canada ICOS Antibody Revenue (2018-2029) & (US$ Million)
Figure 46. Europe ICOS Antibody Sales Market Share by Type (2018-2029)
Figure 47. Europe ICOS Antibody Revenue Market Share by Type (2018-2029)
Figure 48. Europe ICOS Antibody Sales Market Share by Application (2018-2029)
Figure 49. Europe ICOS Antibody Revenue Market Share by Application (2018-2029)
Figure 50. Europe ICOS Antibody Revenue Share by Country (2018-2029)
Figure 51. Europe ICOS Antibody Sales Share by Country (2018-2029)
Figure 52. Germany ICOS Antibody Revenue (2018-2029) & (US$ Million)
Figure 53. France ICOS Antibody Revenue (2018-2029) & (US$ Million)
Figure 54. U.K. ICOS Antibody Revenue (2018-2029) & (US$ Million)
Figure 55. Italy ICOS Antibody Revenue (2018-2029) & (US$ Million)
Figure 56. Russia ICOS Antibody Revenue (2018-2029) & (US$ Million)
Figure 57. China ICOS Antibody Sales Market Share by Type (2018-2029)
Figure 58. China ICOS Antibody Revenue Market Share by Type (2018-2029)
Figure 59. China ICOS Antibody Sales Market Share by Application (2018-2029)
Figure 60. China ICOS Antibody Revenue Market Share by Application (2018-2029)
Figure 61. Asia ICOS Antibody Sales Market Share by Type (2018-2029)
Figure 62. Asia ICOS Antibody Revenue Market Share by Type (2018-2029)
Figure 63. Asia ICOS Antibody Sales Market Share by Application (2018-2029)
Figure 64. Asia ICOS Antibody Revenue Market Share by Application (2018-2029)
Figure 65. Asia ICOS Antibody Revenue Share by Region (2018-2029)
Figure 66. Asia ICOS Antibody Sales Share by Region (2018-2029)
Figure 67. Japan ICOS Antibody Revenue (2018-2029) & (US$ Million)
Figure 68. South Korea ICOS Antibody Revenue (2018-2029) & (US$ Million)
Figure 69. China Taiwan ICOS Antibody Revenue (2018-2029) & (US$ Million)
Figure 70. Southeast Asia ICOS Antibody Revenue (2018-2029) & (US$ Million)
Figure 71. India ICOS Antibody Revenue (2018-2029) & (US$ Million)
Figure 72. Middle East, Africa and Latin America ICOS Antibody Sales Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America ICOS Antibody Revenue Market Share by Type (2018-2029)
Figure 74. Middle East, Africa and Latin America ICOS Antibody Sales Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America ICOS Antibody Revenue Market Share by Application (2018-2029)
Figure 76. Middle East, Africa and Latin America ICOS Antibody Revenue Share by Country (2018-2029)
Figure 77. Middle East, Africa and Latin America ICOS Antibody Sales Share by Country (2018-2029)
Figure 78. Brazil ICOS Antibody Revenue (2018-2029) & (US$ Million)
Figure 79. Mexico ICOS Antibody Revenue (2018-2029) & (US$ Million)
Figure 80. Turkey ICOS Antibody Revenue (2018-2029) & (US$ Million)
Figure 81. Israel ICOS Antibody Revenue (2018-2029) & (US$ Million)
Figure 82. GCC Countries ICOS Antibody Revenue (2018-2029) & (US$ Million)
Figure 83. ICOS Antibody Value Chain
Figure 84. ICOS Antibody Production Process
Figure 85. Channels of Distribution
Figure 86. Distributors Profiles
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed